Results 281 to 290 of about 100,511 (312)

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Lancet, The, 2012
Paulus Kirchhof, Ursula Ravens, Karl Wegscheider   +2 more
exaly  

Antiarrhythmic versus antidysrhythmic: Antiarrhythmic is preferable

American Journal of Health-System Pharmacy, 1987
openaire   +2 more sources

New antiarrhythmic drugs for treatment of atrial fibrillation

Lancet, The, 2010
Dobromir Dobrev, Stanley Nattel
exaly  

Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes.

Heart Rhythm, 2017
N. Hartmann, S. Pabel, Jonas Herting, Felix Schatter, A. Renner, J. Gummert, H. Schotola, B. Danner, L. Maier, N. Frey, G. Hasenfuss, T. Fischer, S. Sossalla   +12 more
semanticscholar   +1 more source

Antiarrhythmic Drug Therapy for Atrial Fibrillation.

Heart Failure Clinics, 2016
M. R. Sardar, W. Saeed, P. Kowey
semanticscholar   +1 more source

Antiarrhythmics

Reactions Weekly, 2020
openaire   +2 more sources

Antiarrhythmics

2018
Mathew George, Lincy Joseph, Sujith K
openaire   +2 more sources

Accuracy of the Ventricular Tachycardia-Induction Study for Predicting Long-Term Efficacy and Inefficacy of Antiarrhythmic Drugs

New England Journal of Medicine, 1980
Roger A Winkle
exaly  

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation, 2012
Peter Zimetbaum
exaly  

Antiarrhythmic properties of ranolazine: A review of the current evidence.

International Journal of Cardiology, 2015
Tanush Gupta, S. Khera, D. Kolte, W. Aronow, S. Iwai   +4 more
semanticscholar   +1 more source